Leduc Vinicius Riberio, Santos Fernando Augusto de Vasconcellos, Oliveira Paula Segato Vaz de, Lomba Gabrielle Stéphanie de Paula da, Figueiredo Gabriela Dias de, Kalil Joana Pereira, Wainstein Alberto Julius Alves, Drummond-Lage Ana Paula
Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, MG, Brazil.
Oncad Surgical Oncology, Belo Horizonte, MG, Brazil.
Arq Bras Cir Dig. 2022 Jan 5;34(3):e1617. doi: 10.1590/0102-672020210002e1617. eCollection 2022.
Due to the longer life expectancy and consequently an increase in the elderly population, a higher incidence of gastric cancer is expected in this population in the coming decades.
To compare the results of laparoscopic GC surgical treatment between individuals aged<65 years (group I) and ≥ 65 years (group II), according to clinical, surgical, and histopathological characteristics.
A observational retrospective study was performed by analyzing medical charts of patients with gastric cancer undergoing total or subtotal laparoscopic gastrectomy for curative purposes by a single oncologic surgery team.
Thirty-six patients were included in each group. Regarding the ASA classification, 31% of the patients in group I was ASA 1, compared to 3.1% in group II. The mean number of concomitant medications in group II was statistically superior to group I (5±4.21 x 1.42±3.08, p<0.001). Subtotal gastrectomy was the most performed procedure in both groups (69.4% and 63.9% in groups I and II, respectively) due to the high prevalence of distal tumors in both groups, 54.4% group I and 52.9% group II. According to Lauren's classification, group I presented a predominance of diffuse tumors (50%) and group II the intestinal type (61.8%). There was no difference between the two groups regarding the number of resected lymph nodes and lymph node metastases and the days of hospitalization and mortality.
Laparoscopic gastrectomy showed to be a safe procedure, without a statistical difference in morbidity, mortality, and hospitalization time between both groups.
由于预期寿命延长,老年人口随之增加,预计在未来几十年该人群中胃癌发病率会更高。
根据临床、手术及组织病理学特征,比较年龄<65岁(I组)和≥65岁(II组)个体的腹腔镜胃癌手术治疗结果。
通过分析由单一肿瘤外科团队进行的旨在根治的全腹腔镜或次全腹腔镜胃切除术的胃癌患者病历,开展一项观察性回顾性研究。
每组纳入36例患者。关于美国麻醉医师协会(ASA)分级,I组31%的患者为ASA 1级,而II组为3.1%。II组伴随用药的平均数量在统计学上高于I组(5±4.21对1.42±3.08,p<0.001)。由于两组远端肿瘤患病率高,次全胃切除术是两组中最常施行的手术(I组和II组分别为69.4%和63.9%),I组为54.4%,II组为52.9%。根据劳伦分类法,I组以弥漫型肿瘤为主(50%),II组以肠型为主(61.8%)。两组在切除淋巴结数量、淋巴结转移情况、住院天数和死亡率方面无差异。
腹腔镜胃切除术是一种安全的手术,两组在发病率、死亡率和住院时间方面无统计学差异。